Author, P. year | Year | Country, income | Study setting | Sample size | Time of assessment | Tool used | Prevalence |
---|---|---|---|---|---|---|---|
Dindar I et al. 2007 | 2007 | Middle | HI | 679 | birth to 48 weeks | EPDS | 25.6% |
Ege E et al. 2008 | 2008 | Middle | community | 364 | 6 to 48 weeks | EPDS | 33.2% |
Flores-Quijano ME et al., 2008 | 2008 | Middle | HI | 163 | 2 to 12 weeks | EPDS | 24.5% |
Hasselmann MH et al., 2008 | 2008 | Middle | HI | 429 | birth to 8 weeks | EPDS | 35.8% |
Tannous L et al., 2008 | 2008 | Middle | community | 271 | 6 to 8 weeks | EPDS | 20.7% |
Durat and Kutlu, 2010 | 2009 | Middle | HI | 126 | birth to 48 weeks | EPDS | 23.8% |
Yagmur Y et al., 2010 | 2010 | Middle | community | 730 | birth to 48 weeks | EPDS | 21.0% |
Botino M et al., 2012 | 2012 | Middle | HI | 811 | birth to 20 weeks | EPDS | 24.3% |
Goker A et al., 2012 | 2012 | Middle | HI | 318 | 4 to 48 weeks | EPDS | 31.4% |
Pocan Ag et al., 2013 | 2013 | Middle | HI | 187 | 4 to 6 weeks | EPDS | 28.9% |
Melo Jr. EF et al., 2012 | 2012 | Middle | HI | 555 | 4 to 6 weeks | EPDS | 10.8% |
Mathisen SE et al. 2013 | 2013 | Middle | HI | 87 | 4 to 6 weeks | EPDS | 37.2% |
Serhan N et al. 2013 | 2012 | Middle | community | 110 | 8 to 24 weeks | EPDS | 9.1% |
de Castro et al 2015 | 2014 | Middle | HI | 604 | birth to 36 weeks | EPDS | 10.6% |
Lara MA et al., 2015 | 2014 | Middle | HI | 210 | 24 weeks | SCID-I | 13.4% |
Corrêa H et al., 2016 | 2016 | Middle | HI | 3060 | birth to 48 weeks | EPDS | 19.5% |
Robert A et al., 2016 | 2016 | Middle | HI | 194 | birth to 6 weeks | EPDS | 40.2% |
Ho-Yen SD et al. 2007 | 2007 | Low | community | 426 | 4 to five weeks | EPDS | 4.9% |
Baghianimoghadam et al, 2009 | 2007 | Middle | HI | 120 | 1 to 16 weeks | BDI | 58.8% |
Gao L et al., 2009 | 2008 | Middle | HI | 130 | 6 to 8 weeks | EPDS | 13.8% |
Kadir AA, et al., 2009 | 2009 | Middle | HI | 293 | 4 to 6 weeks | EPDS | 27.3% |
Wan EY et al., 2009 | 2009 | Middle | HI | 342 | 6 to 8 weeks | EPDS | 15.5% |
Petrosyan D, et al.,2011 | 2011 | Middle | HI | 437 | 3 months | EPDS | 14.4% |
Ahmed HM et al., 2012 | 2012 | Middle | HI | 1000 | 6 to 8 weeks | EPDS | 28.4% |
Hegde S et al. 2012 | 2012 | Middle | HI | 150 | 6 to 14 weeks | EPDS | 15.5% |
Zainal NZ et al. 2012 | 2012 | Middle | HI | 411 | 6 to 8 weeks | MINI | 6.8% |
Swapan G et al. 2013 | 2013 | Middle | HI | 202 | 6 weeks | PRIME MD | 15.8% |
Panyayong B et al., 2013 | 2013 | Middle | community | 1731 | 6 to 8 weeks | EPDS | 8.4% |
Abdollahi F et al., 2014 | 2014 | Middle | HI | 1801 | 8 to 12 weeks | EPDS | 4.5% |
Deng AW et al., 2014 | 2014 | Middle | community | 1823 | 4 weeks | EPDS | 27.4% |
El-Hachem C et al. 2014 | 2014 | Middle | HI | 228 | 4 weeks | EPDS | 12.0% |
Giri RK et al. 2015 | 2015 | Low | HI | 346 | 6 to 10 weeks | EPDS | 30.0% |
Yusuff ASM et al. 2015 | 2015 | Middle | HI | 2072 | 4 to 24 weeks | EPDS | 14.3% |
Murray L et al. 2015 | 2015 | Middle | HI | 431 | 4 to 24 weeks | EPDS | 18.1% |
Shivalli S et al. 2015 | 2015 | Middle | HI | 102 | 4 to 6 weeks | EPDS | 31.4% |
Abdollahi et al. 2014 | 2014 | Middle | HI | 1910 | 12 weeks | EPDS | 19.0% |
Safadi RR et al. 2016 | 2016 | Low | HI | 315 | 12 weeks | PHQ-9 | 25.0% |
Iranpour S et al. 2017 | 2017 | Middle | community | 360 | 12 weeks | EPDS | 34.8% |
Liu S et al. 2017 | 2017 | Middle | community | 882 | 4 weeks | EPDS | 6.7% |
Ramchandani PG et al. 2009 | 2008 | Middle | community | 1035 | 24 weeks | PDQ | 16.4% |
Stewart RC et al. 2010 | 2009 | Middle | HI | 501 | 36 weeks | DSM-IV | 13.9% |
Hassanein I et al. 2014 | 2014 | Low | Hi | 290 | 12 weeks | EPDS | 39.0% |
Mohammed ES et al. 2014 | 2014 | Low | community | 200 | 56 weeks | EPDS | 49.5% |
Khalifa DS et al. 2015 | 2015 | Low | HI | 300 | 12 weeks | EPDS | 9.2% |
Stellenberg E et al. 2015 | 2016 | Middle | community | 159 | 6 to 14 weeks | EPDS | 50.3% |
Weobong B et al. 2013 | 2016 | Middle | community | 13, 360 | 4 weeks | PHQ-9 | 3.8% |
Shamu S et al., 2008 | 2016 | Low | HI | 842 | 6 weeks | CES-D | 21.4% |
Azale A et al. 2016 | 2016 | Low | Community | 385 | 24 weeks | PHQ_9 | 12.1% |
Surkan PJ et al. 2009 | 2009 | Middle | HI | 595 | 24 to 48 weeks | CES-D | 56.0% |
Machado MC et al. 2014 | 2014 | Middle | HI | 168 | 4 t0 12 weeks | EPDS | 16.1% |
Gausia K et al. 2010 | 2010 | Low | Community | 318 | 6 to 8 weeks | EPDS | 20.1% |
Upadhyay AK et al. 2016 | 2016 | Middle | Community | 1833 | 20 to 84 weeks | SRQ-20 | 29.8% |
Islam MJ et al. 2017 | 2016 | Low | Community | 426 | 24 weeks | EPDS | 35.2% |
Saeed Q et al. 2016 | 2016 | Low | Community | 325 | 96 weeks | AKUADS | 40.0% |
Ndokera R et al. 2008 | 2008 | Middle | community | 278 | 8 to 48 weeks | SRQ-20 | 9.7% |
Guo N et al. 2013 (Ghana) | 2013 | Middle | HI | 654 | 12 weeks | PHQ_9 | 8.9% |
Guo N et al. 2013(Ivory Coast) | 2013 | Middle | HI | 654 | 12 weeks | PHQ_9 | 11.8% |
Weobong B et al. 2015 | 2017 | Middle | Community | 16,560 | 4 to 12 weeks | DSM-IV | 3.5% |